MedTech Acquisition Corporation Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MTACU and buy or sell other stocks, ETFs, and their options commission-free!About MTACU
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.
CEOMary T. Szela, MBA
CEOMary T. Szela, MBA
Employees110
Employees110
HeadquartersWestminster, Colorado
HeadquartersWestminster, Colorado
Founded
Founded
Employees110
Employees110
MTACU Key Statistics
Market cap566.27M
Market cap566.27M
Price-Earnings ratio-57.12
Price-Earnings ratio-57.12
Dividend yield—
Dividend yield—
Average volume475.20
Average volume475.20
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$11.43
52 Week high$11.43
52 Week low$9.23
52 Week low$9.23
Stock Snapshot
As of today, MedTech Acquisition Corporation Unit(MTACU) shares are valued at $11.35. The company's market cap stands at 566.27M, with a P/E ratio of -57.12.
On 2025-12-07, MedTech Acquisition Corporation Unit(MTACU) stock opened at —, reached a high of —, and a low of —.
The MedTech Acquisition Corporation Unit(MTACU)'s current trading volume is 0, compared to an average daily volume of 475.2.
In the last year, MedTech Acquisition Corporation Unit(MTACU) shares hit a 52-week high of $11.43 and a 52-week low of $9.23.
In the last year, MedTech Acquisition Corporation Unit(MTACU) shares hit a 52-week high of $11.43 and a 52-week low of $9.23.